What is the further workup for a woman with hyperandrogenism (elevated testosterone levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hyperandrogenism in Women

Measure morning total testosterone (8-10 AM) and repeat if elevated to confirm, then proceed with DHEAS, free testosterone or calculated free testosterone (cFT), and sex hormone-binding globulin (SHBG) to determine the source and severity of androgen excess. 1

Initial Laboratory Testing

First-Line Androgen Assessment

  • Obtain morning total testosterone between 8 AM and 10 AM and repeat if elevated to confirm the finding, as testosterone levels can vary 1, 2
  • Measure DHEAS when total testosterone is twice the upper limit of normal (or >2-3 SD above reference range) to distinguish adrenal from ovarian sources 3, 4
    • DHEAS >600 mg/dL suggests androgen-secreting adrenal cortical adenoma 3
    • Normal DHEAS with very high testosterone suggests ovarian hyperthecosis or androgen-secreting ovarian tumor 3

Free Testosterone Measurement

  • Obtain free testosterone by equilibrium dialysis (gold standard) or calculated free testosterone (cFT) along with SHBG, especially in obese patients 1, 2
  • cFT has pooled sensitivity of 0.89 and specificity of 0.83 for detecting biochemical hyperandrogenism 2
  • Free androgen index (FAI) is an alternative with sensitivity of 0.78 and specificity of 0.85 2
  • LC-MS/MS methods are superior to direct immunoassays for testosterone measurement, with higher accuracy 2

Assay Method Considerations

  • If using immunoassays and results don't match clinical picture, consider diethyl ether extraction to rule out laboratory interference 4
  • Direct immunoassays have lower specificity (0.78) compared to LC-MS/MS (0.92) or immunoassay after extraction (0.93) 2

Severity-Based Diagnostic Approach

Mild Hyperandrogenism (Testosterone <2x Upper Limit)

  • Measure LH and FSH to evaluate for polycystic ovary syndrome (PCOS) 1
  • Check 17-hydroxyprogesterone (17-OHP) to exclude non-classical congenital adrenal hyperplasia (NCCAH) 5
    • Elevated basal or ACTH-stimulated 17-OHP confirms NCCAH 5
  • Measure prolactin to exclude hyperprolactinemia, particularly with recent-onset oligomenorrhea 5

Severe Hyperandrogenism (Testosterone >2-3x Upper Limit or Virilization)

  • Immediately evaluate for androgen-secreting tumors of ovarian or adrenal origin 3, 4, 6
  • Measure DHEAS, testosterone, 17β-estradiol, 17-OH progesterone, androstenedione, 11-deoxycorticosterone, progesterone when suspected adrenocortical carcinoma (ACC) or virilization is present 2
  • Perform pelvic ultrasonography to evaluate for ovarian tumors 1
  • Consider adrenal imaging (CT or MRI) when DHEAS is markedly elevated 2, 6

Additional Hormonal Testing

When Cushing's Syndrome is Suspected

  • Perform 1 mg dexamethasone suppression test (DST) taken at 11 PM with serum cortisol measured at 8 AM 2
    • Cortisol <50 nmol/L excludes cortisol hypersecretion 2
    • Cortisol >138 nmol/L indicates cortisol hypersecretion 2
  • Measure 24-hour urinary free cortisol if DST is abnormal 5

For Adrenal Incidentalomas with Hyperandrogenism

  • Screen for pheochromocytoma with plasma or 24-hour urinary metanephrines if adrenal mass has ≥10 Hounsfield units on non-contrast CT 2
  • Measure aldosterone/renin ratio if hypertension or hypokalemia is present 2

Imaging Studies

Ovarian Imaging

  • Pelvic ultrasonography for suspected ovarian source (normal DHEAS with elevated testosterone) 1, 6
  • Ovarian androgen-secreting tumors occur in 1-3 per 1000 patients with hirsutism 6

Adrenal Imaging

  • Adrenal CT or MRI when DHEAS >600 mg/dL or suspected adrenal tumor 2, 6
  • Adrenal tumors are less common than ovarian tumors but cause postmenopausal virilization 6

Important Clinical Caveats

Laboratory Interpretation Pitfalls

  • Obesity lowers SHBG, which may affect total testosterone interpretation and falsely lower values 1, 3
  • Normal testosterone with clear hyperandrogenic symptoms (hirsutism, acne) requires measurement of free testosterone or FAI, as SHBG is reduced in metabolic syndrome 3
  • Commercial laboratory reference ranges (often up to 95 ng/dL) are too broad and miss 84% of hyperandrogenemia cases; upper limit should be approximately 28 ng/dL 7

Timing and Patient Preparation

  • Ensure patient has been out of bed for 2 hours and seated for 5-15 minutes before aldosterone testing 2
  • Potassium repletion and medication substitution may be needed for accurate hormonal assessment 2

Rapid-Onset or Severe Virilization

  • Recent onset of severe hyperandrogenism with virilization demands urgent tumor evaluation 4, 5, 6
  • Very high testosterone levels (>2-3 SD) without virilization should raise suspicion for laboratory interference 4

Baseline Assessments Before Treatment

  • Measure hemoglobin/hematocrit as baseline 1
  • Assess cardiovascular risk factors including lipids, blood pressure, and glucose 1
  • Measure inhibin B in postmenopausal women with hyperandrogenism 6

References

Guideline

Workup for Elevated Testosterone (Hyperandrogenism)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Research

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012

Research

Postmenopausal hyperandrogenism.

Climacteric : the journal of the International Menopause Society, 2022

Research

Serum testosterone levels and reference ranges in reproductive-age women.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.